The in vitro antimicrobial activities of oxolinic acid, flumequine, sarafloxacin, enrofloxacin, and oxytetracycline against strains of bacteria pathogenic to fish (Aerononas salmonicida subsp. salmonicida, atypical A. salmonicida, Vibrio sabnonicida, Vibrio anguillarum, and Yersinia ruckeri) were determined at two different incubation temperatures, 4 and 15°C, by a drug microdilution method. The main objective of the study was to examine the effect of incubation temperature on the in vitro activities of 4-quinolones and oxytetracycline against these bacteria. When tested against A. salmonicida subsp. salmonicida, all of the quinolones examined had MICs two-to threefold higher at 4°C than at 15°C. Similarly, 1.5-to 2-fold higher MICs were recorded for all of the quinolones except sarafloxacin at 4°C than at 15°C when the drugs were tested against V. salmonicida. In contrast to those of the quinolones, the MICs of oxytetracycline were two-to eightfold lower at 4°C than at 15°C against all of the bacterial species tested. Of the antimicrobial agents tested against the bacterial species included in the study, enrofloxacin was the most active and oxytetracycline was the least active. Sarafloxacin was slightly more active than flumequine and oxolinic acid, especially against oxolinic acid-resistant A. salmonicida subsp. salmonicida strains.
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In recent years, the 4-quinolone antimicrobial compounds oxolinic acid and flumequine, in addition to oxytetracycline, and sulfadiazine-trimethoprim, have been the most frequently used antimicrobial agents in Norwegian aquaculture (18, 23) .
Substantial development of oxolinic acid and tetracycline resistance in bacteria pathogenic to fish (2, 19, 29, 31 ) has led to a need for new antimicrobial drugs for control of bacterial fish diseases in aquaculture. Aminopenicillins, several sulfonamide-trimethoprim combinations, chloramphenicol analogs such as thiamphenicol and florfenicol, and potent fluoroquinolones have all been proposed and tested as potential new drug candidates (2, 3, 12, 16, 21, 24, 25, 30) .
Several of the new fluoroquinolones generated during the last decade (32) show increased inhibitory (6, 15) and bactericidal (4) activities in vitro against many bacterial pathogens, compared with the old 4-quinolones, such as nalidixic acid and oxolinic acid. Studies have also revealed that the newer compounds show increased potency (2, 25) , as well as more effective bactericidal activity (3, 21) , against bacteria pathogenic to fish.
Along the Norwegian coastline, there are significant seasonal and geographic seawater temperature variations, from just above zero in the winter to well above 18°C in the summer at the same site. The most common bacterial fish diseases in Norway, furunculosis, vibriosis, cold water vibriosis, bacterial kidney disease, yersiniosis, and infections caused by different strains of atypical Aeromonas salmonicida, may all occur at a wide range of temperatures.
The general influence of temperature on the pharmacokinetic properties of drugs in fish is well known (9, 10, 11, 13) . However, less attention has been paid to the possible impact * Corresponding author. of temperature on the antimicrobial susceptibilities of specific bacterial fish pathogens.
The aims of this study were to examine the influence of incubation temperature on the in vitro activities of 4-quinolones and oxytetracycline against fish-pathogenic bacteria; to compare the potencies of oxolinic acid, three different fluoroquinolones, and oxytetracycline against common bacteria pathogenic to fish; and to observe whether crossresistance occurs between old 4-quinolones and new fluoroquinolones. (24) . According to previous antimicrobial disc diffusion test results, approximately one-half of theA. salmonicida subsp. salmonicida strains had a known history of quinolone or tetracycline resistance. With reference to the MICs of oxolinic acid against A. salmonicida subsp. salmonicida obtained in this study, the A. salmonicida subsp. salmonicida strains were grouped by the criterion of Tsoumas et al. (31) .
MATERIALS
The strains whose oxolinic acid MICs were less than 1.0 ,ug/ml (the cutoff MIC for oxolinic acid) were classified as oxolinic acid susceptible, and those having oxolinic acid MICs equal to or higher than 1.0,ug/ml were classified as oxolinic acid resistant. By using previously encountered susceptibility and pharmacokinetic data for enrofloxacin as presented by Tsoumas et al. (31) and Bowser et al. (13) , the cutoff MIC of enrofloxacin was determined to be 0.5 p,g/ml.
During these in vitro susceptibility studies, occasional growth of test strains was observed in assay wells containing antimicrobial agents at concentrations above the MICs of all of the drugs tested. Two such drug-resistant A. salmonicida subsp. salmonicida strains were selected for further studies. Each was selected spontaneously in the presence of sarafloxacin or oxytetracycline, respectively, at concentrations 4 and 16 times above the recorded MICs for the susceptible parent strains.
Antimicrobial agents. Enrofloxacin was obtained from Bayer AG, Leverkusen, Germany, and sarafloxacin was from Abbott Laboratories, North Chicago, Ill., while flumequine, oxolinic acid, and oxytetracycline, were purchased from Sigma Chemical Co., St. Louis, Mo.
Antimicrobial solutions. Antibacterial solutions were made as described by Martinsen et al. (24), by dissolving the quinolones in 0.1 N NaOH and oxytetracycline in distilled water before addition of modified Mueller-Hinton broth (24) . The antimicrobial agent concentrations in the test wells before inoculation ranged from 0.0005 to 512,g/ml.
Bacterial inocula. Single bacterial colonies obtained from pure cultures on blood agar plates (blood agar base [Difco Laboratories, Detroit, Mich.] containing 5% citrated bovine blood and 2% NaCl) incubated aerobically at 15°C for 48 h were used. Each strain was inoculated into tubes containing 10 ml of modified Mueller-Hinton broth and incubated at 15°C on a roller drum (Bellco Glass Inc., Vineland, N.J.) at 25 rotations per min. Strains were incubated aerobically as follows: Y ruckeri for 24 h, V. anguillarum and A. salmonicida subsp. salmonicida for 48 h, and V. salmonicida and atypical A. salmonicida for 72 h. By using McFarland nephelometer standard no. 1 (22) , followed by consecutive dilutions in 0.9% saline, the inoculum was diluted to approximately S x 105 CFU/ml before transfer to microtiter tray wells.
MIC assay. MICs were determined at 4 and 15°C by a broth microdilution method (24, 26) . After inoculation, the test wells contained antimicrobial agent concentrations ranging from 256 to 0.00025 ,ug/ml, and the final bacterial test inoculum was 2.5 x 105 CFU/ml in a total volume of 100 pl.
The microtiter trays were sealed with transparent plastic covers and incubated aerobically for 6 days. Four identical trays were made for each antimicrobial agent, of which two were incubated at 4°C and two were incubated at 15°C. 
RESULTS
The in vitro antimicrobial activities of enrofloxacin, sarafloxacin, flumequine, oxolinic acid, and oxytetracycline against 92 bacterial strains at 15 and 4°C are shown in Table   1 . Individual MICs are the means of replicate results done twice for each temperature. At both temperatures, enrofloxacin was the most active agent (P < 0.001) against all of the bacterial species included in the study, whereas oxytetracycline was the least active (P < 0.001). Generally, sarafloxacin was slightly more active than flumequine and oxolinic acid (P = 0.005), especially against oxolinic acid-resistant strains of A. salmonicida subsp. salmonicida (P < 0.001).
When tested against A. salmonicida subsp. salmonicida, all of the quinolones had two-to threefold higher MICs at 4°C than at 15°C. These temperature-dependent differences in antimicrobial activity were statistically significant (P < 0.001). Likewise, statistically significant 1.5-to 2-fold higher MICs were obtained at 4°C than at 15°C for all of the quinolones except sarafloxacin when the drugs were tested against V. salmonicida (for enrofloxacin, P = 0.014; for flumequine, P = 0.041; for oxolinic acid, P = 0.008). There were no statistically significant differences in the MICs of the four quinolones at the two incubation temperatures against atypical A. salmonicida, V. anguillarum, and Y ruckeri.
However, against Y ruckeri, an analogous temperature dependency was noticed.
In contrast to those of the quinolones, the MICs of oxytetracycline were much lower at 4°C than at 15°C. Enrofloxacin and, to a lesser extent, sarafloxacin were more active than oxolinic acid and flumequine against oxolinic acid-resistant strains. According to the proposed enrofloxacin cutoff MIC (0.5 ,ug/ml), 31 (70.5%) and 38 (86.4%) of the A. salmonicida subsp. salmonicida strains were susceptible to enrofloxacin at 4 and 15°C, respectively. Enrofloxacin was also the most active drug against oxolinic acidsusceptible strains. The differences in activity among quinolones were most pronounced against oxolinic acidresistant strains. Furthermore, oxytetracyclin resistance was observed independently of quinolone resistance. Higher MICs at 4°C than at 15°C could be explained by decreased drug diffusion into bacterial cells at lower temperatures (7, 17) and diminished drug availability at the site of action. An additional explanation is that the growth rate of these organisms is low at 4°C, making them less susceptible to the DNA gyrase-inhibitory activity of quinolones. A more hypothetical explanation could be that the affinity of the quinolones for the DNA gyrase complex is decreased at lower temperatures, resulting in less efficient inhibition of DNA synthesis (14, 27) . In these cases, elevated levels of quinolone antimicrobial agents would be required for bacterial growth inhibition at low temperatures.
Lower MICs of oxytetracycline were obtained at 4°C than at 15°C against all of the bacterial species tested. Recently, corresponding results have been observed for tetracycline against V. salmonicida and for trimethoprim and sulfonamides against A. salmonicida, V. anguillarum, V. salmonicida, and Y ruckeni (28) . Lower MICs as a response to decreased incubation temperatures can hardly be explained by membrane permeability variations. However, alterations in the energy-dependent active transport mechanisms for tetracyclines in bacterial membranes, or a temperaturedependent mode of action at the bacterial ribosome, could be possible explanations for the increased oxytetracycline susceptibility found at lower temperatures. These theoretical explanations require further investigation.
In fish, the bioavailability and plasma drug levels of quinolones and oxytetracycline are reduced by low temperatures (9, 11, 13) (18, 23) , resulting in increased selection for oxolinic acid resistance (20) .
Complete cross-resistance between quinolones has previously been demonstrated for various bacterial species (2, 5, 31) . This was confirmed in the present study (Fig. 1) for the four 4-quinolones examined, as tested against strains of A. salmonicida subsp. salmonicida. However, the cross-resis- (2, 3, 25) , have lower resistance mutation frequencies (25, 30) , and exhibit better in vitro bactericidal activity (3, 21) against bacterial species pathogenic to fish than do the old 4-quinolones. Only preliminary pharmacokinetic and efficacy studies with fish are available for the fluoroquinolones (11, 13, 16) . Therefore, further pharmacokinetic and efficacy studies for each fluoroquinolone in both freshwater and marine environments at different temperatures are essential to evaluate the potential use of these substances in the treatment of bacterial diseases of fish.
